Published in Virology on June 20, 2004
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer (2006) 6.59
Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99
Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe (2010) 3.78
Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst (2009) 3.77
Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis (2011) 3.44
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer (2009) 3.15
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog (2006) 2.65
Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A (2006) 2.64
Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis (2008) 2.58
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
The fecal viral flora of wild rodents. PLoS Pathog (2011) 2.51
Arrangement of L2 within the papillomavirus capsid. J Virol (2008) 2.37
Prophylactic human papillomavirus vaccines. J Clin Invest (2006) 2.36
In vivo mechanisms of vaccine-induced protection against HPV infection. Cell Host Microbe (2010) 2.24
How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 2.23
Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis (2009) 2.10
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci U S A (2008) 2.00
Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol (2008) 1.96
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst (2009) 1.95
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94
Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis (2008) 1.93
Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol (2006) 1.92
Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol (2008) 1.90
The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis (2011) 1.87
Giant magnetoresistive biochip for DNA detection and HPV genotyping. Biosens Bioelectron (2008) 1.84
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res (2010) 1.82
Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One (2011) 1.80
Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions. PLoS Pathog (2012) 1.79
Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol (2006) 1.78
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer (2008) 1.77
Ancient papillomavirus-host co-speciation in Felidae. Genome Biol (2007) 1.75
The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res (2012) 1.75
Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection. CMAJ (2007) 1.72
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2. J Virol (2007) 1.70
Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol (2007) 1.66
A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis (2007) 1.62
Oncogenic activities of human papillomaviruses. Virus Res (2009) 1.60
Risk factors for anogenital human papillomavirus infection in men. J Infect Dis (2007) 1.59
Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol (2005) 1.57
Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol (2009) 1.55
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol (2008) 1.54
Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis (2007) 1.54
Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res (2010) 1.50
Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A (2006) 1.48
Viruses associated with human cancer. Biochim Biophys Acta (2007) 1.47
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. Hum Vaccin (2011) 1.46
Human papillomavirus genome variants. Virology (2013) 1.45
Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics (2009) 1.45
Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog (2008) 1.44
Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol (2009) 1.40
Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol (2006) 1.38
Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer (2009) 1.37
Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types. J Clin Microbiol (2007) 1.36
Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis (2010) 1.35
Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. J Virol (2009) 1.35
Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol (2008) 1.35
Full genome virus detection in fecal samples using sensitive nucleic acid preparation, deep sequencing, and a novel iterative sequence classification algorithm. PLoS One (2014) 1.34
Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol (2005) 1.34
Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol (2011) 1.33
Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci U S A (2006) 1.32
Partitioning the genetic diversity of a virus family: approach and evaluation through a case study of picornaviruses. J Virol (2012) 1.31
Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure (2012) 1.30
Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis (2010) 1.30
Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol (2006) 1.29
A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2. PLoS One (2011) 1.28
The papillomavirus E7 proteins. Virology (2013) 1.28
Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J Virol (2012) 1.28
Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J (2007) 1.27
Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS One (2009) 1.25
Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virol J (2010) 1.25
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11. Vaccine (2006) 1.25
Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep (2006) 1.24
A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls. PLoS One (2013) 1.23
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology (2012) 1.23
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23
An armamentarium of wart treatments. Clin Med Res (2006) 1.23
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol (2005) 1.22
Papillomavirus E6 oncoproteins. Virology (2013) 1.21
Replication and assembly of human papillomaviruses. J Dent Res (2009) 1.20
Sequence imputation of HPV16 genomes for genetic association studies. PLoS One (2011) 1.20
Use of mobile telemedicine for cervical cancer screening. J Telemed Telecare (2011) 1.20
Identification of a novel human papillomavirus by metagenomic analysis of samples from patients with febrile respiratory illness. PLoS One (2013) 1.19
Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol (2008) 1.19
Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ (2010) 1.18
Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol (2009) 1.18
Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics (2009) 1.18
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS One (2007) 1.18
Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett (2010) 1.17
Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology (2006) 1.16
Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J Virol (2012) 1.14
Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Pannonica Adriat (2011) 1.14
Papillomaviruses: Viral evolution, cancer and evolutionary medicine. Evol Med Public Health (2015) 1.13
Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study. BMJ Open (2011) 1.12
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res (2004) 2.21
HPV vaccine for all. Lancet (2009) 2.10
Support for Greece. Science (2012) 2.07
Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev (2009) 1.97
The Cassava Genome: Current Progress, Future Directions. Trop Plant Biol (2012) 1.75
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol (2003) 1.72
Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol (2004) 1.62
The natural history of human papillomavirus infections of the mucosal epithelia. APMIS (2010) 1.61
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA (2009) 1.60
Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol (2004) 1.56
Open letter: let us treat patients in Syria. Lancet (2013) 1.49
The cassava (Manihot esculenta Crantz) root proteome: protein identification and differential expression. Proteomics (2006) 1.44
SV40 in human cancers--an endless tale? Int J Cancer (2003) 1.43
The BioCassava plus program: biofortification of cassava for sub-Saharan Africa. Annu Rev Plant Biol (2011) 1.40
Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology (2006) 1.33
A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol (2003) 1.28
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol (2005) 1.22
Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci U S A (2004) 1.22
Human papillomavirus & cervical cancer. Indian J Med Res (2009) 1.20
Streptococcus bovis: causal or incidental involvement in cancer of the colon? Int J Cancer (2006) 1.20
Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope (2004) 1.19
Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J Virol (2004) 1.16
Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology (2004) 1.16
Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase. J Virol (2004) 1.15
Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology (2009) 1.15
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology (2004) 1.11
Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem (2011) 1.11
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol (2008) 1.09
Chaperone proteins abrogate inhibition of the human papillomavirus (HPV) E1 replicative helicase by the HPV E2 protein. Mol Cell Biol (2002) 1.07
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology (2005) 1.06
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy. Vaccine (2012) 1.06
High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology (2006) 1.05
Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer (2008) 1.05
Inferring the evolutionary history of rice yellow mottle virus from genomic, phylogenetic, and phylogeographic studies. J Virol (2004) 1.04
Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus. J Virol (2006) 1.04
Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology (2008) 1.04
Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer (2007) 1.02
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02
Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J Virol (2007) 1.01
Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and -b. J Virol (2005) 0.99
Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation. J Virol (2002) 0.99
High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology (2010) 0.99
PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro. Mol Cancer (2011) 0.98
Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia. Virology (2013) 0.96
TT viruses--the still elusive human pathogens. Preface. Curr Top Microbiol Immunol (2009) 0.96
Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. J Med Virol (2010) 0.96
Retrovirus-mediated gene transfer to analyze HPV gene regulation and protein functions in organotypic "raft" cultures. Methods Mol Med (2005) 0.95
Where next for genome sequencing? Science (2006) 0.95
mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. J Virol (2003) 0.95
Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J Mol Med (Berl) (2007) 0.95
Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. J Acquir Immune Defic Syndr (2005) 0.95
Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells. J Biol Chem (2004) 0.94
Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes. J Virol (2006) 0.94
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene (2002) 0.92
Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures. Mol Cancer Ther (2004) 0.92
A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions. Cell Cycle (2009) 0.92
Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog (2005) 0.92
HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. Virology (2004) 0.91
Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis? Int J Cancer (2009) 0.90
Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol (2005) 0.89
The promoter of the human proliferating cell nuclear antigen gene is not sufficient for cell cycle-dependent regulation in organotypic cultures of keratinocytes. J Biol Chem (2002) 0.88
Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells. J Virol (2002) 0.87
The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1. Virology (2003) 0.87
Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature. Trends Microbiol (2010) 0.87
Heterogeneity of TT virus related sequences isolated from human tumour biopsy specimens. J Mol Med (Berl) (2001) 0.86
Simultaneous in situ detection of RNA, DNA, and protein using tyramide-coupled immunofluorescence. Methods Mol Biol (2005) 0.86
HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proc Natl Acad Sci U S A (2013) 0.85
Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein. J Mol Biol (2007) 0.85
Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells. Virology (2008) 0.84
Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1/2 signaling. Life Sci (2012) 0.82
A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16. Virology (2003) 0.82
Obligation for cell line authentication: appeal for concerted action. Int J Cancer (2010) 0.81
New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer. Life Sci (2012) 0.81
Significance and possible causes of false-negative results of reflex human Papillomavirus infection testing. Cancer (2007) 0.81
Stability of rice yellow mottle virus and cellular compartmentalization during the infection process in Oryza sativa (L.). Virology (2002) 0.81
Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. PLoS One (2012) 0.80
Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Wound Repair Regen (2006) 0.80
Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells. Life Sci (2012) 0.79
Human papillomavirus infections: warts or cancer? Cold Spring Harb Perspect Biol (2013) 0.78
Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cells. J Biol Chem (2004) 0.78
NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2. Biochim Biophys Acta (2005) 0.78
Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein. J Virol (2011) 0.77
Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients. J Low Genit Tract Dis (2010) 0.77
Robust HPV-18 production in organotypic cultures of primary human keratinocytes. Methods Mol Biol (2015) 0.76
Q&A: On the case. Interview by Michelle Grayson. Nature (2012) 0.76
Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes. J Virol (2003) 0.76
Analysis of the regulation of viral transcription. Methods Mol Med (2005) 0.76
Analysis of HPV DNA replication using transient transfection and cell-free assays. Methods Mol Med (2005) 0.76
Association of single nucleotide polymorphisms of nicotinic acetylcholine receptor subunits with cervical neoplasia. Life Sci (2012) 0.75
[Infections and oncology: viruses as a cause of colorectal cancer]. Dtsch Med Wochenschr (2014) 0.75
In the near future, our readership can look forward to reading the "editor's choice". Int J Cancer (2009) 0.75
[Papillomavirus vaccines as a "quick-shot with a lack of precision"?]]. Pharm Unserer Zeit (2009) 0.75
Science addict. Nature (2011) 0.75
Assessment of the HPV DNA methylation status in cervical lesions. Methods Mol Biol (2015) 0.75
Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference-HPV2001. Virus Res (2002) 0.75
Conflicts of interest: the responsibility of the authors and editors of the International Journal of Cancer. Int J Cancer (2006) 0.75